Cargando…
Clozapine for treatment resistance in early psychosis: a survey of UK clinicians’ training, knowledge and confidence
BACKGROUND: Clozapine is the only medication licenced for patients with psychosis that is resistant to conventional antipsychotic treatment. However, despite its effectiveness, it remains widely underutilised. One contributory factor for this may be clinicians’ lack of confidence around the manageme...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806412/ https://www.ncbi.nlm.nih.gov/pubmed/36601352 http://dx.doi.org/10.1177/20451253221141222 |